Beskrivelse
In 1997, Novo Nordisk scientist Lotte Bjerre Knudsen managed to turn the short-lived GLP-1 hormone into a long-acting drug candidate. However, the initial test failed as the dose was set too low. And the company could not immediately start a new trial. Victory is still far from assured. Follow “A steak well done”, Episode 3 of the Novo Nordisk Foundation’s 2022 Advent Calendar “The Story of GLP-1”.
